NLG-SIBSSM supervised
ING Group
ING GROEP N.V.
549300NYKK9MWM7GGW15Resolution authority: Single Resolution Board
CET1 ratio
13.26%
Total capital ratio
18.23%
Leverage ratio
4.28%
MREL requirement
22.62%
MREL resources
32.32%
Internal MREL
Not disclosedLiquidity coverage ratio
139%
Net stable funding ratio
128%
Capital-stack instruments
| ISIN | Instrument | Seniority | Coupon | Maturity▴ | Amount |
|---|---|---|---|---|---|
| XS2526852350 | INGA 5.0 30/08/26 | SP | 5% | 2026-08-30 | GBP 0 |
| XS2443920249 | INGA 1.250 02/16/27 '26 MTN | SP | 1.25% | 2027-02-16 | EUR 0 |
| US456837AV55 | INGA 1.726 01/04/27 | SP | 1.726% | 2027-04-01 | USD 1,100m |
| US456837AX12 | INTNED 4/1/27 c26 (FRN) ING GROEP | SP | Not disclosed | 2027-04-01 | USD 400m |
| US456837BF96 | INGA 6.083 09/11/27 '26 FRN | SP | 6.083% | 2027-09-11 | USD 1,250m |
| US456837BJ19 | INGA 6.521 09/11/27 '26 FRN | SP | Not disclosed | 2027-09-11 | USD 500m |
| XS2554746185 | INGA 4.875 14/11/27 | SP | 4.875% | 2027-11-14 | EUR 1,250m |
| XS1730885073 | ING Groep N.V. EO-Med.-Term Nts 2017(28) | T2 | 1.375% | 2028-01-11 | EUR 1,000m |
| XS1796077946 | INTNED 4.7 03/22/28 BOND | T2 | 4.7% | 2028-03-22 | USD 1,250m |
| US456837BB82 | INGA 4.017 03/28/28 '27 FRN | SP | 4.017% | 2028-03-28 | USD 1,250m |
| XS1590823859 | INTNED 3 04/11/28 BOND | T2 | 3% | 2028-04-11 | EUR 1,000m |
| XS1882544973 | ING Groep N.V. EO-Med.-T.Resolut.Nts 2018(28) | SP | 2% | 2028-09-20 | EUR 1,500m |
| XS2390506546 | ING Groep N.V. EO-FLR Med.-T. Nts 2021(27/28) | SP | 0.375% | 2028-09-29 | EUR 1,500m |
| US456837AM56 | INGA 4.550 10/02/28 | SP | 4.55% | 2028-10-02 | USD 1,250m |
| XS2305598216 | INGGR1.125%7DEC28 | SP | 1.125% | 2028-12-07 | GBP 800m |
| XS1939254568 | INGGroep 3 92% 23 01 2029 | SP | 3.92% | 2029-01-23 | NOK 750m |
| XS1564394796 | INGA 2.5 15/02/29 | T2 | 2.5% | 2029-02-15 | EUR 750m |
| XS2258452478 | ING Groep N.V. EO-FLR Non-Pref.Nts 20(28/29) | SP | 0.25% | 2029-02-18 | EUR 1,250m |
| XS1968711876 | INTNED 1 5/8 03/21/29 | SP | 1.625% | 2029-03-21 | EUR 138m |
| US456837BP78 | INGA 5.189 03/25/29 '28 FRN | SP | Not disclosed | 2029-03-25 | USD 750m |
| US456837BQ51 | $ ING Groep 29 | SP | 4.858% | 2029-03-25 | USD 750m |
| US456837AQ60 | INGA 4.050 04/09/29 | SP | 4.05% | 2029-04-09 | USD 1,000m |
| XS2624976077 | ING Groep N.V. EO-FLR Med.-T. Nts 2023(28/29) | SP | 4.5% | 2029-05-23 | EUR 1,500m |
| XS1917902196 | INGGROEP5%5JUN29 | SP | 5% | 2029-06-05 | AUD 175m |
| XS2764264607 | INGGR3.875%12AUG29 | SP | 3.875% | 2029-08-12 | EUR 1,250m |
| XS2909716321 | INGGR4.875%02OCT29 | SP | 4.875% | 2029-10-02 | GBP 500m |
| XS2729201413 | INGR1.503%07DEC29 | SP | 1.503% | 2029-12-07 | JPY 24,900m |
| XS2281155254 | ING Groep N.V. EO-FLR Med.-T. Nts 2021(29/30) | SP | 0.25% | 2030-02-01 | EUR 1,500m |
| US456837BL64 | INGA 5.335 03/19/30 '29 FRN | SP | 5.335% | 2030-03-19 | USD 1,500m |
| XS2891742731 | ING Groep N.V. EO-FLR Med.-T. Nts 2024(29/30) | SP | 3.5% | 2030-09-03 | EUR 1,500m |
| XS3225326282 | ING GROEP NV FX 2.875% NOV30 CALL EUR | SP | 2.875% | 2030-11-10 | EUR 1,000m |
| XS1909186451 | ING GROEP TF 2,5% NV30 EUR | SP | 2.5% | 2030-11-15 | EUR 1,500m |
| XS2413697140 | ING Groep N.V. EO-FLR Med.-T. Nts 2021(29/30) | SP | 0.875% | 2030-11-29 | EUR 750m |
| XS1918892586 | INGGroep 3 79% 13 12 2030 | SP | 3.79% | 2030-12-13 | NOK 1,500m |
| XS1944307955 | INGGroep 5% 31 01 2031 | SP | 5% | 2031-01-31 | AUD 130m |
| XS2443920751 | ING Groep N.V. EO-FLR Med.-T. Nts 2022(30/31) | SP | 1.75% | 2031-02-16 | EUR 1,500m |
| XS1965536490 | INGGR1.998%19MAR31 | SP | 1.998% | 2031-03-19 | EUR 45m |
| US456837BR35 | INGA 5.066 03/25/31 '30 FRN | SP | 5.066% | 2031-03-25 | USD 1,000m |
| XS2176621170 | INGA 2.125 26/05/31 | T2 | 2.125% | 2031-05-26 | EUR 0 |
| XS3002547563 | ING Groep N.V. EO-FLR Med.-T. Nts 2025(30/31) | SP | 3% | 2031-08-17 | EUR 1,250m |
| XS3291116955 | ING Groep N.V. EO-FLR Med.-T. Nts 2026(31/32) | SP | 3.125% | 2032-02-10 | EUR 1,250m |
| US456837BU63 | INGA 4.803 03/23/32 '31 FRN | SP | 4.803% | 2032-03-23 | USD 1,500m |
| US456837AW39 | INGA 2.727 04/01/32 '31 FRN | SP | 2.727% | 2032-04-01 | USD 750m |
| XS2350756446 | ING Groep N.V. EO-FLR Med.-Term Nts 21(27/32) | T2 | 0.875% | 2032-06-09 | EUR 500m |
| XS1634362054 | ING GROUP NV 4.25 23JUN17-2032 | SP | 4.25% | 2032-06-23 | USD 160m |
| XS1683357252 | INGGROEP4%14SEP32 | T2 | 4% | 2032-09-14 | USD 100m |
| XS3226561143 | ING GROEP NV FX 4.875% SEP32 CALL GBP | SP | 4.875% | 2032-09-17 | GBP 500m |
| XS2407529309 | ING Groep N.V. EO-FLR Cap.Med.T.Nts 21(27/32) | T2 | 1% | 2032-11-16 | EUR 1,000m |
| XS2941482569 | ING Groep N.V. EO-FLR Med.-T. Nts 2024(31/32) | SP | 3.375% | 2032-11-19 | EUR 1,000m |
| US456837BC65 | INGA 4.252 03/28/33 '32 FRN | SP | 4.252% | 2033-03-28 | USD 1,000m |
| XS2588986724 | INGGR6.25%20MAY33 | T2 | 6.25% | 2033-05-20 | GBP 750m |
| XS2524746687 | ING Groep N.V. EO-FLR Med.T.Nts 22(28/33) | T2 | 4.125% | 2033-08-24 | EUR 1,000m |
| XS2554745708 | ING Groep N.V. EO-FLR Med.-T. Nts 2022(32/33) | SP | 5.25% | 2033-11-14 | EUR 1,000m |
| XS2729201504 | INGR1.878%07DEC33 | SP | 1.878% | 2033-12-07 | JPY 15,800m |
| XS2421195178 | INGGR0.975%14FEB34 | SP | 0.975% | 2034-02-14 | EUR 100m |
| XS2449218093 | INGGR1.876%24FEB34 | SP | 1.876% | 2034-02-24 | EUR 75m |
| XS2624977554 | ING Groep N.V. EO-FLR Med.-T. Nts 2023(33/34) | SP | 4.75% | 2034-05-23 | EUR 1,500m |
| XS2818300407 | ING Groep N.V. EO-FLR Med.T.Nts 24(29/34) | T2 | 4.375% | 2034-08-15 | EUR 1,250m |
| US456837BH52 | INGA 6.114 09/11/34 '33 FRN | SP | 6.114% | 2034-09-11 | USD 1,250m |
| XS2764264789 | ING Groep N.V. EO-FLR Med.-T. Nts 2024(34/35) | SP | 4% | 2035-02-12 | EUR 1,250m |
| XS2588986997 | ING Groep N.V. EO-FLR Med.T.Nts 23(29/35) | T2 | 5% | 2035-02-20 | EUR 500m |
| US456837BM48 | INGA 5.550 03/19/35 '34 FRN | SP | 5.55% | 2035-03-19 | USD 1,500m |
| XS2886191589 | ING Groep N.V. EO-FLR Med.T.Nts 24(30/35) | T2 | 4.25% | 2035-08-26 | EUR 1,250m |
| XS2891741923 | ING Groep N.V. EO-FLR Med.-T. Nts 2024(34/35) | SP | 3.75% | 2035-09-03 | EUR 1,250m |
| US456837BS18 | INGA 5.525 03/25/36 '35 FRN | SP | 5.525% | 2036-03-25 | USD 1,000m |
| XS3074495444 | ING Groep N.V. EO-FLR Med.T.Nts 25(31/36) | T2 | 4.125% | 2036-05-20 | EUR 1,250m |
| XS3002547647 | ING Groep N.V. EO-FLR Med.-T. Nts 2025(35/36) | SP | 3.5% | 2036-08-17 | EUR 1,500m |
| XS3291117763 | ING Groep N.V. EO-FLR Med.-T. Nts 2026(36/37) | SP | 3.75% | 2037-02-10 | EUR 1,250m |
| US456837BV47 | $ ING Groep 37 | SP | 5.42% | 2037-03-23 | USD 1,500m |
| XS3153087559 | INGGR3.875%20AUG37 | T2 | 3.875% | 2037-08-20 | EUR 1,250m |
| XS3379640363 | ING Groep N.V. EO-FLR Med.-T. Nts 2026(33/38) | T2 | 4.25% | 2038-05-18 | EUR 1,000m |
| NL0000113587 | INTNED Float PERP | AT1 | 0% | Perpetual | EUR 750m |
| US456837AF06 | ING GROEP N.V. USD 1250000000 6.500% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 6.5% | Perpetual | USD 1,250m |
| US456837AR44 | ING GROEP N.V. U.S.$1,500,000,000, 5.750% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 5.75% | Perpetual | USD 1,500m |
| US456837AY94 | ING GROEP N.V. US$ 1,000,000,000 3.875% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 3.875% | Perpetual | USD 1,000m |
| US456837AZ69 | ING GROEP N.V. $1,000,000,000 4.25% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 4.25% | Perpetual | USD 1,000m |
| US456837BT90 | ING GROEP N.V. $1,500,000,000 7.000% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 7% | Perpetual | USD 1,500m |
| XS1497755360 | ING GROEP N.V. USD 1000000000 6.875% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 6.875% | Perpetual | USD 1,000m |
| XS1956051145 | ING GROEP N.V. U.S.$ 1,250,000,000 6.750% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 6.75% | Perpetual | USD 0 |
| XS2122174415 | ING Groep N.V. DL-FLR Cap. Secs 2020(29/Und.) | T2 | 4.875% | Perpetual | USD 750m |
| XS2585240984 | ING GROEP N.V. U.S.$ 1,000,000,000 7.500% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 7.5% | Perpetual | USD 1,000m |
| XS2761357594 | ING GROEP N.V. U.S.$ 1,250,000,000 8.00% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 8% | Perpetual | USD 1,250m |
| XS2885225966 | ING GROEP N.V. U.S.$ 1,000,000,000 7.250% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 7.25% | Perpetual | USD 1,000m |
| XS3282781460 | ING GROEP N.V. US$ 1,500,000,000 6.500% Perpetual Additional Tier 1 Contingent Convertible Capital Securities | AT1 | 6.5% | Perpetual | USD 1,500m |
XS2526852350INGA 5.0 30/08/26
XS2443920249INGA 1.250 02/16/27 '26 MTN
US456837AV55INGA 1.726 01/04/27
US456837AX12INTNED 4/1/27 c26 (FRN) ING GROEP
US456837BF96INGA 6.083 09/11/27 '26 FRN
US456837BJ19INGA 6.521 09/11/27 '26 FRN
XS2554746185INGA 4.875 14/11/27
XS1730885073ING Groep N.V. EO-Med.-Term Nts 2017(28)
XS1796077946INTNED 4.7 03/22/28 BOND
US456837BB82INGA 4.017 03/28/28 '27 FRN
XS1590823859INTNED 3 04/11/28 BOND
XS1882544973ING Groep N.V. EO-Med.-T.Resolut.Nts 2018(28)
XS2390506546ING Groep N.V. EO-FLR Med.-T. Nts 2021(27/28)
US456837AM56INGA 4.550 10/02/28
XS2305598216INGGR1.125%7DEC28
XS1939254568INGGroep 3 92% 23 01 2029
XS1564394796INGA 2.5 15/02/29
XS2258452478ING Groep N.V. EO-FLR Non-Pref.Nts 20(28/29)
XS1968711876INTNED 1 5/8 03/21/29
US456837BP78INGA 5.189 03/25/29 '28 FRN
US456837BQ51$ ING Groep 29
US456837AQ60INGA 4.050 04/09/29
XS2624976077ING Groep N.V. EO-FLR Med.-T. Nts 2023(28/29)
XS1917902196INGGROEP5%5JUN29
XS2764264607INGGR3.875%12AUG29
XS2909716321INGGR4.875%02OCT29
XS2729201413INGR1.503%07DEC29
XS2281155254ING Groep N.V. EO-FLR Med.-T. Nts 2021(29/30)
US456837BL64INGA 5.335 03/19/30 '29 FRN
XS2891742731ING Groep N.V. EO-FLR Med.-T. Nts 2024(29/30)
XS3225326282ING GROEP NV FX 2.875% NOV30 CALL EUR
XS1909186451ING GROEP TF 2,5% NV30 EUR
XS2413697140ING Groep N.V. EO-FLR Med.-T. Nts 2021(29/30)
XS1918892586INGGroep 3 79% 13 12 2030
XS1944307955INGGroep 5% 31 01 2031
XS2443920751ING Groep N.V. EO-FLR Med.-T. Nts 2022(30/31)
XS1965536490INGGR1.998%19MAR31
US456837BR35INGA 5.066 03/25/31 '30 FRN
XS2176621170INGA 2.125 26/05/31
XS3002547563ING Groep N.V. EO-FLR Med.-T. Nts 2025(30/31)
XS3291116955ING Groep N.V. EO-FLR Med.-T. Nts 2026(31/32)
US456837BU63INGA 4.803 03/23/32 '31 FRN
US456837AW39INGA 2.727 04/01/32 '31 FRN
XS2350756446ING Groep N.V. EO-FLR Med.-Term Nts 21(27/32)
XS1634362054ING GROUP NV 4.25 23JUN17-2032
XS1683357252INGGROEP4%14SEP32
XS3226561143ING GROEP NV FX 4.875% SEP32 CALL GBP
XS2407529309ING Groep N.V. EO-FLR Cap.Med.T.Nts 21(27/32)
XS2941482569ING Groep N.V. EO-FLR Med.-T. Nts 2024(31/32)
US456837BC65INGA 4.252 03/28/33 '32 FRN
XS2588986724INGGR6.25%20MAY33
XS2524746687ING Groep N.V. EO-FLR Med.T.Nts 22(28/33)
XS2554745708ING Groep N.V. EO-FLR Med.-T. Nts 2022(32/33)
XS2729201504INGR1.878%07DEC33
XS2421195178INGGR0.975%14FEB34
XS2449218093INGGR1.876%24FEB34
XS2624977554ING Groep N.V. EO-FLR Med.-T. Nts 2023(33/34)
XS2818300407ING Groep N.V. EO-FLR Med.T.Nts 24(29/34)
US456837BH52INGA 6.114 09/11/34 '33 FRN
XS2764264789ING Groep N.V. EO-FLR Med.-T. Nts 2024(34/35)
XS2588986997ING Groep N.V. EO-FLR Med.T.Nts 23(29/35)
US456837BM48INGA 5.550 03/19/35 '34 FRN
XS2886191589ING Groep N.V. EO-FLR Med.T.Nts 24(30/35)
XS2891741923ING Groep N.V. EO-FLR Med.-T. Nts 2024(34/35)
US456837BS18INGA 5.525 03/25/36 '35 FRN
XS3074495444ING Groep N.V. EO-FLR Med.T.Nts 25(31/36)
XS3002547647ING Groep N.V. EO-FLR Med.-T. Nts 2025(35/36)
XS3291117763ING Groep N.V. EO-FLR Med.-T. Nts 2026(36/37)
US456837BV47$ ING Groep 37
XS3153087559INGGR3.875%20AUG37
XS3379640363ING Groep N.V. EO-FLR Med.-T. Nts 2026(33/38)
NL0000113587INTNED Float PERP
US456837AF06ING GROEP N.V. USD 1250000000 6.500% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
US456837AR44ING GROEP N.V. U.S.$1,500,000,000, 5.750% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
US456837AY94ING GROEP N.V. US$ 1,000,000,000 3.875% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
US456837AZ69ING GROEP N.V. $1,000,000,000 4.25% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
US456837BT90ING GROEP N.V. $1,500,000,000 7.000% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
XS1497755360ING GROEP N.V. USD 1000000000 6.875% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
XS1956051145ING GROEP N.V. U.S.$ 1,250,000,000 6.750% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
XS2122174415ING Groep N.V. DL-FLR Cap. Secs 2020(29/Und.)
XS2585240984ING GROEP N.V. U.S.$ 1,000,000,000 7.500% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
XS2761357594ING GROEP N.V. U.S.$ 1,250,000,000 8.00% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
XS2885225966ING GROEP N.V. U.S.$ 1,000,000,000 7.250% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
XS3282781460ING GROEP N.V. US$ 1,500,000,000 6.500% Perpetual Additional Tier 1 Contingent Convertible Capital Securities
90 active instruments in total; 6 structured products and other debt not shown here. See all 90 in the explorer →